Current Transplant News and Events | Page 2

Current Transplant News and Events, Transplant News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Could a poo transplant one day be the secret of eternal youth?
Poo transplants could one day be used to restore cognitive decline among the elderly - according to new research. A new study published today shows how faecal transplants from older to younger mice altered their gut microbiome, which in turn impacted their spatial learning and memory. The research team hope the reverse could also be true, and one day used as a therapy to restore cognitive function in older people. (2020-10-02)

Are organ transplant recipients at greater risk of death from COVID-19?
A new study analyzes death risk from COVID-19 in organ transplant recipients and finds one treatment method greatly increased the risk. (2020-10-01)

UM171 saves another life
Developed in Canada, the UM171 molecule was used in a blood transplant by a Montreal medical team on a young man suffering from severe aplastic anemia, an autoimmune disease. (2020-09-30)

Pioneering dual surgery a safe option for patients with polycystic kidney disease
Patients with large polycystic kidneys in need of a kidney transplant can have their diseased kidneys safely removed laparoscopically at the same time as their transplant surgery. That is the finding of a Mayo Clinic study recently published in the American Journal of Transplantation. (2020-09-29)

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature. Cardiologists from the Mazankowski Alberta Heart Institute at the University of Alberta joined teams from Cambridge, Boston and Berlin to use state-of-the-art analytical techniques to sequence the ribonucleic acids (RNA) in nine types of single cells from six regions of the heart. (2020-09-24)

Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death
Antifungal preventive medications reduce mortality risk by half in the first year following lung transplantation, according to Mayo Clinic research involving 667 patients who received lung transplants from 2005 to 2018. (2020-09-23)

Study finds gut microbiome plays important role in sleep regulation
Obstructive sleep apnea (OSA) affects more than one billion people worldwide. Evidence suggests OSA can alter the gut microbiome (GM) and may promote OSA-associated co-morbidities, including diabetes, hypertension and cognitive problems. Researchers from the University of Missouri School of Medicine have discovered how OSA-related sleep disturbances affect the gut microbiome in mice and how transplanting those gut bacteria into other mice can cause changes to sleep patterns in the recipient mice. (2020-09-23)

Yale succeeds with a more inclusive approach to heart transplants
Doctors at Yale New Haven Hospital used a more aggressive selection process to more than quadruple the number of heart transplants performed there while maintaining positive patient outcomes, according to a new study. (2020-09-18)

Heart transplants from severely obese donors show comparable outcomes for patients
An analysis of more than 26,000 heart transplant patients found that recipients of hearts from donors with severe obesity had similar post-transplant outcomes to recipients with non-obese donors. Nearly 40% of US adults are obese, and the prevalence of severe obesity has doubled over the past 15 years. (2020-09-16)

Tailored education system to benefit kidney transplant patients
Researchers find their computer-tailored education system, 'Your Path to Transplant' increases knowledge and readiness to pursue kidney transplant. (2020-09-16)

Imaging agent developed at Washington University spotlights inflammation
Researchers at Washington University School of Medicine in St. Louis have created a new PET imaging agent that detects signs of inflammation. Such a tracer could aid diagnosis and study of diseases ranging from cardiovascular disease to cancer to COVID-19. (2020-09-14)

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne. The study was published on 8 September in Cell Reports. (2020-09-08)

Key priorities for transplant and living donor advocacy during COVID-1
Researchers describe ways to achieve optimal patient advocacy for kidney recipients and donors during the COVID-19 pandemic and beyond. (2020-09-04)

Tiny biological package gets drug right to the 'heart' of transplant rejection
For patients who receive a heart transplant in the near future, the old adage, 'Good things come in small packages,' may become words to live by. In a recent study, researchers at Johns Hopkins Medicine and the National Cancer Institute (NCI) demonstrated in mice that they can easily deliver a promising anti-rejection drug directly to the area surrounding a grafted heart by packaging it within a tiny three-dimensional, protein gel cocoon known as a hydrogel. (2020-09-03)

Kidneys infected with hepatitis C can be safely transplanted into healthy recipients
Kidneys infected with hepatitis C can be safely transplanted into healthy recipients (2020-09-02)

Microgel immuno-acceptance method could improve pancreatic islet transplant success
Researchers at the Georgia Institute of Technology and University of Missouri have developed a new microgel drug delivery method that could extend the effectiveness of pancreatic islet transplantations -- from several years to possibly the entire lifespan of a recipient. (2020-08-31)

Rejuvenating old organs could increase donor pool
Investigators from Brigham and Women's Hospital are leading efforts to breathe new life into older organs by leveraging a new class of drugs known as senolytics, which target and eliminate old cells. (2020-08-27)

Ratio of two proteins may add kidneys to the transplant donor pool
An investigation by researchers at Johns Hopkins Medicine, in collaboration with researchers at 13 other medical institutions in the United States, has shown that two proteins found in deceased donor urine can be measured to define which donor organs -- including those with AKI -- are the best candidates for saving the lives of patients with kidney failure. (2020-08-18)

Immune response to Sars-Cov-2 following organ transplantation
Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2. A test helps to adapt therapy following an infection. (2020-08-17)

Biodiversity may limit invasions: Lessons from lizards on Panama Canal islands
Introduced species can become invasive, damaging ecosystems and disrupting economies through explosive population growth. One mechanism underlying population expansion in invasive populations is 'enemy release', whereby the invader experiences relaxation of agonistic interactions with other species, including parasites. (2020-08-09)

Experts issue back-to-school guidelines for pediatric solid organ transplant recipients
As school districts look ahead to a very different school year, pediatric infectious disease experts from across the United States convened to outline back-to-school safety guidelines for solid organ transplant (SOT) recipients. The group, led by Kevin J. Downes, MD, attending physician in the Division of Pediatric Infectious Diseases at Children's Hospital of Philadelphia (CHOP), published their recommendations today in the Journal of the Pediatric Infectious Diseases Society. (2020-08-04)

UArizona Health Sciences researcher seeks safer, more effective leukemia treatment
A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences. The procedure is known as a haploidentical (half-matched) bone marrow transplantation, or ''haplo-BMT,'' providng an alternate source of stem cells for patients needing a bone marrow transplant but unable to find a perfect or near-perfect donor match for human leukocyte antigens. (2020-08-03)

Double surgery improves chances for heart transplant in patients with obesity
Pairing bariatric surgery with LVAD heart surgery may be an effective bridge to heart transplant for obese patients. (2020-07-27)

Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital stays
Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital readmissions and resulted in shorter hospital stays when patients were readmitted (2020-07-27)

Heart transplants declined sharply during pandemic
Heart transplants, donor hearts, and transplant waitlists all fell sharply at the start of the COVID-19 pandemic in the United States, Columbia University researchers have found. (2020-07-24)

Kidney transplant, the cost of accounting for patients' preferences
Taking into account patients' preferences can help speed up the organ allocation process and improve the life quality of the recipients, as shown by a joint study conducted by Ca' Foscari University and the University of Padua (2020-07-17)

Moffitt researchers identify factors to predict severe toxicities in CAR T patients
In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers identify possible factors that could help physicians know if patients are at higher risk for severe adverse events before they receive CAR T therapy. (2020-07-15)

Sylvester researchers identify protein target that might ease graft versus host disease
Researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine publish findings on how inhibiting the STING protein pathway can help protect against a complication from stem cell transplants. (2020-07-15)

New hope for kidney revival for transplant
Cell therapy delivered directly to the kidney can revive a 'marginal' organ, improving function and could offer new hope for providing more kidneys for transplant. (2020-07-14)

Human lungs rejected for transplant recovered using novel technique
A multidisciplinary team from Vanderbilt University Medical Center (VUMC) and Columbia University has demonstrated that injured human donor lungs declined for transplant can be recovered by cross-circulation between the human lung and a xenogeneic host. (2020-07-13)

COVID-19 in patients who have received kidney transplants or are undergoing dialysis
A recent study found that most kidney transplant recipients with COVID-19 do not need to be hospitalized. Another study found that patients on dialysis who develop COVID-19 may have symptoms that are different from other patients with the infectious disease. (2020-07-07)

First successful delivery of mitochondria to liver cells in animals
This experiment marks the first time researchers have ever successfully introduced mitochondria into specific cells in living animals. The study lays the groundwork to address a serious gap in treatment for liver diseases and may even eventually be used to treat other maladies throughout the body affected by mitochondrial malfunction or damage. (2020-06-25)

Study finds HCV-positive livers safe for transplantation; Patients cured afterward
UC researchers find similar results for positive outcomes when comparing patients receiving livers infected with hepatitis C to patients who receive livers without infection. (2020-06-22)

Liver perfusion could save 7 in 10 rejected donor livers
A major study investigating the effectiveness of liver perfusion as a technique to improve the function of donor livers that would have otherwise been rejected has shown that up to 7 in every 10 could be used after just 4-6 hours of the assessment. (2020-06-17)

Call for caution for using a CAR-T immunotherapy against acute myeloid leukemia
Researchers from the Josep Carreras Leukaemia Research Institute prove that the preclinical implementation of Acute Myeloid Leukaemia immunotherapy, based on CD123-redirected CAR T-cells, affects hematopoiesis, blood cells production, and reconstitution. (2020-06-17)

Diabetic mice improve with retrievable millimeter-thick cell-laden hydrogel fiber
Researchers from The University of Tokyo developed a novel fiber-shaped hydrogel transplant for the treatment of type 1 diabetes mellitus. They showed that pancreatic cells encapsulated in 1.0-mm-thick hydrogel fibers normalized blood glucose levels in diabetic mice while being protected from foreign body reactions. These findings help facilitate cell-based therapies for type 1 diabetes mellitus. (2020-06-15)

More and safer heart transplants could become possible with new heart box
A donated heart can now be transported and preserved for longer than what has previously been possible. The new method, which consists of a specially designed heart box, was used for a transplant for the first time as early as the summer of 2017. Now it has been evaluated in a first clinical study, and the results are published in Nature Communications. (2020-06-15)

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients. Transplant recipients were shown to require lower levels of immunosuppression in order to prevent organ rejection. This reduces the risk of side effects such as viral infections. Results from this study have been published in The Lancet.* (2020-06-10)

Racial, gender disparities observed in heart transplant recipients with COVID-19 infection
Researchers suggest focusing on disparities to help identify which patients with a heart transplant may be at higher risk for a worse course of COVID-19 infection. (2020-06-09)

Fecal transplants show promise as treatment for non-alcoholic fatty liver disease
A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease (NAFLD). The randomized controlled trial published in The American Journal of Gastroenterology found that fecal transplants in patients with NAFLD result in a reduction in how easily pathogens and other unwanted molecules pass through the human gut and into circulation, known as intestinal permeability. (2020-06-09)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.